
Global Medical REIT
We have no price for Global Medical REIT since 2 April 2026. It may have been taken over, merged or renamed, so the figures below are from then.
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here.
Global Medical REIT vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
Global Medical REIT | No profit yet | ||
Welltower | 191.4× · Very expensive | ||
Ventas | 187.1× · Very expensive | ||
Omega Healthcare Investors | 25.4× · Fair price | ||
Healthpeak Properties | 203.3× · Very expensive |
AI analysis
An AI analyst reads Global Medical REIT's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- −3.8%
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
What analysts expect
- Average price target
- $20.92
- Range
- $11.00 – $40.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Feb 25, 2026 | 1.10 | 0.07 | +1,592.3% |
| Nov 4, 2025 | 1.12 | 1.05 | +6.7% |
| Aug 5, 2025 | 1.15 | 1.15 | +0.0% |
| May 7, 2025 | 0.22 | 0.22 | +0.0% |
| Feb 27, 2025 | 0.22 | 0.01 | +2,100.0% |
| Nov 6, 2024 | 0.22 | 0.23 | −4.3% |
| Aug 6, 2024 | 0.22 | 0.22 | +0.0% |
| May 7, 2024 | 0.23 | 0.24 | −4.2% |
News
Global oil supplies are suddenly flowing. Why a crude glut won’t mean cheaper diesel.MarketWatch · Nov 13, 2026Global Cyber Warfare Market Set to Reach $80.09 Billion by 2030 as Geopolitical Tensions Accelerate Investment | Microsoft, Lockheed Martin, RTX, and CrowdStrike Vie for ShareYahoo Finance · Nov 13, 2026Global Military Edge Computing Market Report 2026: Size, Trends and Forecast to 2030 | Capitalize on 16% CAGR with Microsoft, AWS, RTX, Lockheed Martin, and NVIDIAYahoo Finance · Nov 13, 2026Global AI in Digital Transformation Market Opportunities and Strategies to 2035 | Capture $320.74 Billion in Agentic AI and Cloud Growth with Microsoft, Nvidia, Google, and AmazonYahoo Finance · Nov 13, 2026Kolibri Global Energy GAAP EPS of $0.10 misses by $0.05, revenue of $18.3M beats by $0.97MSeeking Alpha · Nov 13, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Global Medical REIT
Is Global Medical REIT a good stock to buy?
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Global Medical REIT AI analysis
What does Global Medical REIT do?
Global Medical REIT Inc. operates as a specialized real estate investment trust (REIT) focused on net-lease medical office properties. It is in REIT - Healthcare Facilities.
Who are Global Medical REIT's competitors?
The largest listed companies in the same industry are Welltower, Ventas, Omega Healthcare Investors and Healthpeak Properties. The peers table on this page compares their profit, growth and price with Global Medical REIT's.
Prices: daily closes to Apr 2, 2026. Fundamentals: company reports via invest-like data.



